Cargando…

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis

BACKGROUND: Lymphopenia is a marker of poor prognosis in patients with community-acquired pneumonia (CAP), yet its impact on outcomes in patients with CAP and sepsis remains unknown. We aim to investigate the impact of lymphopenia on outcomes, risk of intensive care unit (ICU) admission, and mortali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cilloniz, Catia, Peroni, Héctor José, Gabarrús, Albert, García-Vidal, Carolina, Pericàs, Juan M, Bermejo-Martin, Jesús, Torres, Antoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231373/ https://www.ncbi.nlm.nih.gov/pubmed/34189165 http://dx.doi.org/10.1093/ofid/ofab169

Ejemplares similares

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Host-targeted approaches to sepsis due to community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
por: Cillóniz, Catia, et al.
Publicado: (2020)

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2018)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis
por: Cillóniz, Catia, et al.
Publicado: (2011)

Community-acquired pneumonia in critically ill very old patients: a growing problem
por: Cillóniz, Catia, et al.
Publicado: (2020)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2019)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
por: Cillóniz, Catia, et al.
Publicado: (2018)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2012)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Antimicrobial Resistance Among Streptococcus pneumoniae
por: Cillóniz, Catia, et al.
Publicado: (2018)

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
por: Aliberti, Stefano, et al.
Publicado: (2014)

The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011–2018
por: Torres, Antoni, et al.
Publicado: (2021)

Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49
por: Cillóniz, Catia, et al.
Publicado: (2019)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2021)

Epidemiology, etiology, and risk factors of bacterial pneumonia
por: Torres, Antoni, et al.
Publicado: (2015)

Predicting treatment failure in patients with community acquired pneumonia: a case-control study
por: Martin-Loeches, Ignacio, et al.
Publicado: (2014)

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
por: Cilloniz, Catia, et al.
Publicado: (2016)

Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia
por: Menéndez, Rosario, et al.
Publicado: (2012)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease
por: Crisafulli, Ernesto, et al.
Publicado: (2020)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2018)

Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
por: Ferrer, Miquel, et al.
Publicado: (2015)

Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2–Infected Macaques
por: Koo, Bon-Sang, et al.
Publicado: (2020)

Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia
por: Musher, Daniel M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2fdgua50jsairmfc58s83athrb